|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1691073881 |
003 |
DE-627 |
005 |
20240201064302.0 |
007 |
cr uuu---uuuuu |
008 |
200226s2020 gw |||||o 00| ||eng c |
020 |
|
|
|a 9783527812172
|c electronic bk. : oBook
|9 978-3-527-81217-2
|
020 |
|
|
|a 3527812172
|c electronic bk. : oBook
|9 3-527-81217-2
|
024 |
7 |
|
|a 10.1002/9783527812172
|2 doi
|
035 |
|
|
|a (DE-627)1691073881
|
035 |
|
|
|a (DE-599)KEP049964690
|
035 |
|
|
|a (OCoLC)1130398237
|
035 |
|
|
|a (WILEY)9783527812172
|
035 |
|
|
|a (EBP)049964690
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
041 |
|
|
|a eng
|
044 |
|
|
|c XA-DE
|
050 |
|
0 |
|a RM301.25
|
082 |
0 |
|
|a 615.1/9
|
084 |
|
|
|a 58.28
|2 bkl
|
245 |
1 |
0 |
|a Innovative dosage forms
|b design and development at early stage
|c edited by Yogeshwar G. Bachhav
|
264 |
|
1 |
|a Weinheim, Germany
|b Wiley-VCH
|c 2020
|
300 |
|
|
|a 1 Online-Ressource (xviii, 452 Seiten)
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods and principles in medicinal chemistry
|v volume 76
|
500 |
|
|
|a Includes bibliographical references and index
|
520 |
|
|
|a Impact of the Polymorphic Form of Drugs/NCEs on Preformulation and Formulation Development / MHD Bashir Alsirawan, Anant Paradkar -- Strategies for the Formulation Development of Poorly Soluble Drugs via Oral Route / Sanket Shah, Abhijit Date, Renè Holm -- Effect of Residual Reactive Impurities in Excipients on the Stability of Pharmaceutical Products / Ankit Sharma -- Preclinical Formulation Assessment of NCEs / Raju Saka, Priyadarshini Sathe, Wahid Khan, Sachin Dubey -- Regulatory Aspects for Formulation Design - with Focus on the Solid State / Michael Gruss -- Insight into Innovative Applications of Parenteral Formulations / Clara Fernandes -- Assessing Pharmacokinetics of Various Dosage Forms at Early Stage / Susanne Bonsmann, Joachim Ossig -- Transdermal Medical Devices: Formulation Aspects / Mayank Singhal, César E S Jimenez, Maria Lapteva, Yogeshvar N Kalia -- Physical Characterization Techniques to Access Amorphous Nature / Aniket Sabnis, Niten Jadav, Tim Gough, Adrian Kelly, Anant Paradkar -- Design and Development of Ocular Formulations for Preclinical and Clinical Trials / Mathieu Schmitt -- Preclinical Safety Aspects for Excipients: Oral, IV, and Topical Routes / Florian Engel -- Formulation of Therapeutic Proteins: Strategies for Developing Oral Protein Formulations / Saurabh Patil, Aditya Narvekar, Amita Puranik, Ratnesh Jain, Prajakta Dandekar.
|
650 |
|
0 |
|a Drug development
|
650 |
|
0 |
|a Drugs
|x Dosage
|
700 |
1 |
|
|a Bachhav, Yogeshwar G.
|e herausgeberin
|4 edt
|
776 |
1 |
|
|z 9783527343966
|
830 |
|
0 |
|a Methods and principles in medicinal chemistry
|v volume 76
|9 76
|w (DE-627)1005569525
|w (DE-576)495712914
|w (DE-600)2912484-0
|7 ns
|
856 |
4 |
0 |
|u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172
|m X:WILEY
|x Verlag
|
912 |
|
|
|a ZDB-35-UBC
|
912 |
|
|
|a ZDB-35-WIC
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a ISIL_DE-28
|
912 |
|
|
|a GBV_ILN_120
|
912 |
|
|
|a ISIL_DE-715
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a ISIL_DE-21
|
912 |
|
|
|a GBV_ILN_2020
|
912 |
|
|
|a ISIL_DE-Ch1
|
912 |
|
|
|a GBV_ILN_2111
|
912 |
|
|
|a ISIL_DE-944
|
936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 615.1/9
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 3626997081
|c 00
|f --%%--
|d --%%--
|e s
|j --%%--
|h ACQ
|u CATDESC_WIL-EB
|y z
|z 20-04-20
|
980 |
|
|
|2 62
|1 01
|x 0028
|b 360161930X
|h OLR-Wiley-EBS
|k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt.
|k Temporär im Bestand der UB Rostock
|y z
|z 02-03-20
|
980 |
|
|
|2 120
|1 01
|x 0715
|b 3905804530
|c 00
|f --%%--
|d --%%--
|e g
|j --%%--
|h alma
|y z
|z 10-04-21
|
980 |
|
|
|2 2001
|1 01
|x DE-21
|b 3601374226
|c 00
|f --%%--
|d --%%--
|e --%%--
|j n
|y l01
|z 02-03-20
|
980 |
|
|
|2 2020
|1 01
|x DE-Ch1
|b 4046979518
|c 00
|f --%%--
|d --%%--
|e --%%--
|j n
|k Campuslizenz
|y l01
|z 28-01-22
|
980 |
|
|
|2 2111
|1 01
|x DE-944
|b 3601400537
|c 00
|f --%%--
|d eBook Wiley
|e --%%--
|j n
|k Elektronischer Volltext - Campuslizenz
|y l01
|z 02-03-20
|
981 |
|
|
|2 20
|1 01
|x 0084
|r https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172
|
981 |
|
|
|2 62
|1 01
|x 0028
|r https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172
|
981 |
|
|
|2 120
|1 01
|x 0715
|r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991015328513503501
|
981 |
|
|
|2 2001
|1 01
|x DE-21
|r https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172
|
981 |
|
|
|2 2020
|1 01
|x DE-Ch1
|r https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172
|
981 |
|
|
|2 2111
|1 01
|x DE-944
|r https://onlinelibrary.wiley.com/doi/book/10.1002/9783527812172
|
982 |
|
|
|2 2001
|1 01
|x DE-21
|8 00
|s s
|a eBook-Wiley-UBCM-eBook-Collection-2018
|
983 |
|
|
|2 2111
|1 01
|x DE-944
|8 00
|0 (DE-627)1353370437
|a e-Book
|
995 |
|
|
|2 20
|1 01
|x 0084
|a ACQ
|
995 |
|
|
|2 20
|1 01
|x 0084
|a CATDESC_WIL-EB
|
995 |
|
|
|2 62
|1 01
|x 0028
|a OLR-Wiley-EBS
|
995 |
|
|
|2 120
|1 01
|x 0715
|a alma
|